$CC News

JP Morgan Maintains Neutral on Chemours, Raises Price Target to $22

Chemours (CC) Price Target Increased by 20.11% to 27.41

Morgan Stanley Maintains Equal-Weight on Chemours, Raises Price Target to $21

RBC Capital Maintains Outperform on Chemours, Raises Price Target to $29

UBS Maintains Buy on Chemours, Raises Price Target to $30

The Chemours Company 2026 Q1 - Results - Earnings Call Presentation

The Chemours Company (CC) Q1 2026 Earnings Call Transcript

Full Transcript: Chemours Q1 2026 Earnings Call

Chemours Co/The (NYSE:CC) Slides After Q1 Revenue Miss Offsets EPS Beat

Chemours Affirms FY2026 Sales Guidance of $5.982B-$6.098B vs $5.987B Est

Chemours Sees Q2 2026 Sales $1.588B-$1.657B vs $1.655B Est

Chemours: Thesis Materialization In 2026 (Rating Downgrade)

Truist Securities Maintains Buy on Chemours, Raises Price Target to $30

Chemours (CC) Price Target Increased by 11.18% to 22.82

Is Chemours (CC) Offering Long Term Value After A 105% One Year Rally

Do Reaffirmed Bullish Views On Chemours (CC) Outweigh Its Balance Sheet And Legacy Risks?

HPF Market Forecast by Type, Form, Application, End-Use Industry, and Region to 2030 - Daikin Industries, AGC, and Chemours Co. Lead the Industry, Growing by $2 Billion Through 2030

UBS Maintains Buy on Chemours, Raises Price Target to $29

Truist Securities Maintains Buy on Chemours, Raises Price Target to $27

Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere